Compare Abeona Therapeutics Inc (ABEO) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Under Armour Inc Class A — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: Under Armour Inc Class A is far larger — about 5.4× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| ABEO | UA | |
|---|---|---|
Market Cap | $421.19M | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $7.88 |
52-Week Low | $4.17 | $3.96 |
Enterprise Value | $276.10M | $3.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
